Overview

A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain

Status:
Withdrawn
Trial end date:
2010-12-12
Target enrollment:
0
Participant gender:
All
Summary
The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Karolinska Institutet
Treatments:
Diclofenac
Etoricoxib
Criteria
Inclusion Criteria:

- American Society of Anesthesiology (ASA) physiological class 1-2 patients

- aged 18-65 years

- scheduled for elective hallux valgus surgery in general anesthesia

Exclusion Criteria:

- NSAID allergy

- liver disease

- renal disease

- uncontrolled cardiovascular disease

- Lithium therapy

- chronic pain

- regular analgesia use